After Cough Syrup Deaths, IPC Issues Toolkit to Curb DEG, EG Contamination in Liquid Formulations
IPC
New Delhi: In the wake of multiple incidents of contaminated cough syrups containing Diethylene Glycol (DEG) and Ethylene Glycol (EG), the Indian Pharmacopoeia Commission (IPC) has released a comprehensive free toolkit compiling pharmacopoeial and regulatory resources aimed at strengthening safeguards against Diethylene Glycol (DEG) and Ethylene Glycol (EG) contamination in liquid oral medicines, particularly those used for treating allergies, colds, and coughs.
The IPC, which plays a central role in ensuring the safety, efficacy, and quality of medicines in India, said the toolkit is designed to serve as a comprehensive reference for excipients and raw material suppliers, drug manufacturers, testing laboratories, and regulatory authorities.
The initiative aligns with the government’s heightened focus on preventing toxic glycol contamination, which has been linked to several global incidents of child fatalities.
The newly issued resource compiles key general chapters and monographs from the Indian Pharmacopoeia (IP), reference standards, and relevant international guidance documents. It provides stakeholders with validated methods and frameworks to detect impurities, verify excipient integrity, and maintain compliance with established pharmacopeial standards.
By implementing these references, manufacturers can strengthen quality control mechanisms for high-risk excipients and ensure that liquid oral formulations meet safety norms.
General Chapters and General Monographs in the IP provide foundational principles, standardized test methods, and quality assurance procedures that are applicable across multiple monographs. These chapters serve as essential references for ensuring consistency in analytical testing and manufacturing practices.
In the context of DEG and EG contamination, relevant general chapters offer validated methods and quality control frameworks that help manufacturers detect impurities, assess excipient integrity, and maintain compliance with pharmacopeial standards. By implementing these chapters effectively, stakeholders can strengthen control over high-risk excipients and safeguard the quality and safety of liquid oral formulations.
General Chapter {2.4.13} Gas Chromatography—Analytical procedure for performing gas chromatography
General Monograph Oral Liquids—Mandatory quality tests to be performed on finished formulations
Excipient Monographs Covered
Quality specifications for key excipients prone to contamination have been listed under the following IP monographs:
Glycerin
Liquid Maltitol
Polyethylene Glycol 1500
Polyethylene Glycol 4000
Polyethylene Glycol 6000
Propylene Glycol
Sorbitol Solution (70%) – Crystallising
Availability of IP Reference Standards (IPRS)
To ensure analytical accuracy and result traceability, IPC announced the availability of the following IP Reference Standards (IPRS):
Diethylene Glycol IPRS
Ethylene Glycol IPRS
Glycerin (Glycerol) IPRS
Propylene Glycol IPRS
Sorbitol IPRS
Maltitol (Mannitol Impurity B) IPRS
These standards can be accessed and purchased through the IPC’s online store at https://onlinestore.ipc.gov.in/jspui/products
Queries related to procurement can be addressed to sales-ipc@gov.in
Testing Guidance by IPC
The Commission has also issued a detailed guidance document —
IPC/GD/11: Testing of Diethylene Glycol and Ethylene Glycol in Liquid Orals by Gas Chromatography — providing validated protocols for laboratories conducting DEG and EG analysis.
Legislations and Government Advisories
The toolkit consolidates recent regulatory actions and advisories issued by the Government of India to strengthen quality compliance across the pharmaceutical supply chain:
CDSCO Advisory: Mandating strict compliance with the Drugs Rules, 1945 for testing both raw materials and finished formulations.
G.S.R. 922 (E): Notification on the Revised Schedule M, enhancing Good Manufacturing Practice (GMP) norms.
DGHS Advisory: On the rational use of cough syrups in paediatric populations.
CDSCO Advisory: Emphasizing the use of pharma-grade excipients in all formulations.
NABL-Accredited Labs List: Enumerating approved private testing laboratories authorized for testing cough syrups intended for export.
Supporting Global References
To promote harmonization with international standards, the IPC toolkit also includes:
- WHO TRS 1052, Annex 2: Good Manufacturing Practices (GMP) for Excipients.
- International Pharmacopoeia Test Method: For determining DEG and EG in oral liquid preparations.
To view the official document, click the link below:
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.